IL6 and myeloid sarcoma: Briken et al. [11] reported that following nine weeks of endurance training, people with progressive MS experienced greater elevation (36.2%) in serum IL-6 levels after GXT compared to a wait-list control group (10.3% increase) (p = 0.06).